GRCE — Grace Therapeutics, Inc.
Materials · Pharmaceutical Preparations · Nasdaq
4Insiders filing
4Transactions
+$0Reported buys
−$0Reported sells
0Cluster events
Insiders
| Insider | Role | Txns | Reported value |
|---|---|---|---|
| DelAversano Robert J | Principal Financial Officer | 1 | $0 |
| Macdonald R. Loch | Chief Medical Officer | 1 | $0 |
| Kumar Amresh | VP Program Management | 1 | $0 |
| Kohli Prashant | Chief Executive Officer | 1 | $0 |
Transaction history
| Filing date | Trade date | Ticker | Insider | Type | Shares | Price | Value | Cluster |
|---|---|---|---|---|---|---|---|---|
| 2026-09-01 | 2026-08-28 | GRCE | Kohli Prashant Chief Executive Officer | A routine | 267,160 | — | — | |
| 2026-09-01 | 2026-08-28 | GRCE | Kumar Amresh VP Program Management | A routine | 35,760 | — | — | |
| 2026-09-01 | 2026-08-28 | GRCE | Macdonald R. Loch Chief Medical Officer | A routine | 54,690 | — | — | |
| 2026-09-01 | 2026-08-28 | GRCE | DelAversano Robert J Principal Financial Officer | A routine | 33,660 | — | — |
No transactions match these filters.